Prevention of pneumococcal disease in children ... Which pneumococcal vaccine to use

被引:0
|
作者
Schmidt, S. [1 ]
机构
[1] Amayeza Informat Serv, Roodepoort, South Africa
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Children under five years of age, but especially those under two years of age, are considered to be at increased risk of invasive pneumococcal disease (IPD). Vaccination plays an important role in preventing IPD. Conjugated vaccines have been found to be effective in reducing the disease among young children who have been vaccinated, as well as providing indirect protection (" herd protection") to unvaccinated older children and adults. Polysaccharide vaccines are not effective in children under two years of age and should only be used for children over two years of age who are at an increased risk of invasive disease and its complications. (c) Medpharm
引用
收藏
页码:39 / 44
页数:6
相关论文
共 50 条
  • [31] Epidemiology of Invasive Pneumococcal Disease in Bangladeshi Children Before Introduction of Pneumococcal Conjugate Vaccine
    Saha, Samir K.
    Hossain, Belal
    Islam, Maksuda
    Hasanuzzaman, Md
    Saha, Shampa
    Hasan, Mohammad
    Darmstadt, Gary L.
    Chowdury, Mrittika
    El Arifeen, Shams
    Baqui, Abdullah H.
    Breiman, Robert F.
    Santosham, Mathuram
    Luby, Stephen P.
    Whitney, Cynthia G.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (06) : 655 - 661
  • [32] Increase in invasive pneumococcal disease in children associated with shortage of heptavalent pneumococcal conjugate vaccine
    Abuelreish, Motasem
    Subedar, Asad
    Chiu, Thomas
    Wludyka, Peter
    Rathore, Mobeen
    CLINICAL PEDIATRICS, 2007, 46 (01) : 45 - 52
  • [33] Prevalence of Immunodeficiency in Children With Invasive Pneumococcal Disease in the Pneumococcal Vaccine Era A Systematic Review
    Butters, Coen
    Phuong, Linny Kimly
    Cole, Theresa
    Gwee, Amanda
    JAMA PEDIATRICS, 2019, 173 (11) : 1084 - 1094
  • [34] Prevention of Invasive Pneumococcal Disease: Problems Emerged After Some Years of the 13-Valent Pneumococcal Conjugate Vaccine Use
    Principi, Nicola
    Di Cara, Giuseppe
    Bizzarri, Ilaria
    Isidori, Chiara
    Borgia, Paola
    Mignini, Costanza
    Saponara, Marco
    Argentiero, Alberto
    Esposito, Susanna
    CURRENT INFECTIOUS DISEASE REPORTS, 2018, 20 (01)
  • [35] Prevention of Invasive Pneumococcal Disease: Problems Emerged After Some Years of the 13-Valent Pneumococcal Conjugate Vaccine Use
    Nicola Principi
    Giuseppe Di Cara
    Ilaria Bizzarri
    Chiara Isidori
    Paola Borgia
    Costanza Mignini
    Marco Saponara
    Alberto Argentiero
    Susanna Esposito
    Current Infectious Disease Reports, 2018, 20
  • [36] Use of pneumococcal polysaccharide vaccine in children: what is the evidence?
    Borrow, Ray
    Heath, Paul T.
    Siegrist, Claire-Anne
    CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (03) : 292 - 303
  • [37] Risk Factors for Invasive Pneumococcal Disease in Children in the Era of Conjugate Vaccine Use
    Pilishvili, Tamar
    Zell, Elizabeth R.
    Farley, Monica M.
    Schaffner, William
    Lynfield, Ruth
    Nyquist, Ann-Christine
    Vazquez, Marietta
    Bennett, Nancy M.
    Reingold, Arthur
    Thomas, Ann
    Jackson, Delois
    Schuchat, Anne
    Whitney, Cynthia G.
    PEDIATRICS, 2010, 126 (01) : E9 - E17
  • [38] Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults
    Black, S
    Shinefield, H
    Baxter, R
    Austrian, R
    Elvin, L
    Hansen, J
    Lewis, E
    Fireman, B
    VACCINE, 2006, 24 : S79 - S80
  • [39] Pneumococcal conjugate vaccine in children
    Davis, RL
    Fireman, B
    Shinefield, HR
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01): : 84 - 85
  • [40] PNEUMOCOCCAL VACCINE IN ASPLENIC CHILDREN
    EHRENGUT, W
    KLINISCHE PADIATRIE, 1984, 196 (01): : 58 - 59